Time Source Company Announcement
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Strategic Update
15 Feb 2024 07:00 AM in-vitro siRNA update
15 Feb 2024 07:00 AM Trading update and Notice of General Meeting
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Trading Statement
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Trading Update
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Update on SDC-1801 Clinical Trial Progress
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Share buyback-transaction in own shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM GSK completes acquisition of Aiolos Bio
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Trading Statement
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Issue of Equity, Investment Manager Shareholding
15 Feb 2024 07:00 AM Dokwe Due-Diligence Update
15 Feb 2024 07:00 AM Subscription
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Trading Update
15 Feb 2024 07:00 AM Notification of Dividend (Appendix 3A)
15 Feb 2024 07:00 AM Final Approval to Develop Hermosa's Taylor Deposit
15 Feb 2024 07:00 AM WDS releases Reserves Statement &financial updates
15 Feb 2024 07:00 AM Issue of Debt
15 Feb 2024 07:00 AM Publication of Suppl. to Covered Bond Programme
15 Feb 2024 07:00 AM Publication of Supplement to EMTN Programme
15 Feb 2024 07:00 AM Half Year 2024 Exceptional Items Update
15 Feb 2024 07:00 AM FS prepared in accordance with IFRSs for 6 months
15 Feb 2024 07:00 AM FS prepared in accordance with IFRSs for 9 months
15 Feb 2024 07:00 AM Third Point Releases Q4 2023 Investor Letter
15 Feb 2024 07:00 AM Directorate Change
15 Feb 2024 07:00 AM Settlement of Legal Action
15 Feb 2024 07:00 AM Transaction in Own Shares
15 Feb 2024 07:00 AM Publication of Circular
UK 100

Latest directors dealings